Back to News
Market Impact: 0.3
ResMed (RMD) Beats Q1 Earnings and Revenue Estimates
Source: zacks.com
Corporate EarningsHealthcare & BiotechCompany Fundamentals
ResMed reported quarterly earnings of $2.91 per share, beating the Zacks Consensus Estimate of $2.67 by $0.24, or about 9%. Earnings were up from $2.55 per share a year earlier.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
RMD0.65
More News
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Norwegian shares surge 13% on earnings beat, guidance raise
- Taiwan Stocks Heads for Correction as Global AI Selloff Deepens
- Asia stocks tumble as AI spending concerns deepen; BOJ holds rates